Medically induced glaucoma

Cover Page


Cite item

Full Text

Abstract

The last decades have seen an increase of steroid use in ophthalmology to treat various diseases. These include allergic conjunctivitis, uveitis of different etiologies, age-related macular degeneration, central serous retinopathy, and post-operative complications, etc. In addition, recently, ophthalmologists have noted an increasing frequency of uncontrolled steroid use by patients. This could lead to ocular hypertension and steroid induced glaucoma. Recent data on prevalence, causes and pathogenesis of steroid induced glaucoma are presented in the article.

About the authors

Oksana Petrovna Vitovskaya

Bogomolets National medical university

Email: dschur@mail.ru
doctor of medical science, professor. Department of ophthalmology

References

  1. McLean J. M. Use of ACTH and cortisone. Trans. Am. Ophthalmol. Soc., 1950; 48: 293-96.
  2. Francois J. Cortisone et tension oculaire. Ann. D’Oculist 1954; 187: 805.
  3. Convell L. L. Glaucoma induced by systemic steroid therapy. Am. J. Opbthalmol., 1958; 45: 108-9.
  4. Cubey R. B. Glaucoma following the application of corticosteroid to the skin of the eyelids. Br. Dermatol., 1976; 95: 207-8.
  5. Alfano J. E. Changes in the intraocular pressure associated with systemic steroid therapy. Am. J. Opbtbalmol., 1963; 56: 245.
  6. Armaly M. F. Statistical attributes of the steroid hypertensive response in the clinically normal eye. 1. The demonstration of three level of response. Invest. Opbtbalmol., 1963; 4: 187-97.
  7. Becker B., Hahn K. A. Topical corticosteroids and hereditary in primary open-angle glaucoma. Am. J. Opbtbalmol., 1964; 57: 543- 51.
  8. Herschler J. Intractable intraocular hypertension induced by repository triamcinolone acetonide. Am. J. Ophthalmol., 1972; 74: 501-4.
  9. Kalina R. E. Increased intraocular pressure following subconjunctival corticosteroid administration. Arch. Ophthalmol., 1969; 81: 788-90.
  10. Smithen L. M., Ober M. D., Maranan L., Spaide R. F. Intravitreal triamcinolone acetonide and intraocular pressure. Am. J. Ophthalmol., 2004; 138: 740-43.
  11. Singh I. P., Ahmad S. I., Yeh D. et al. Early rapid rise in intraocular pressure after intravitreal triamcinolone acetonide injection. Am. J. Ophthalmol., 2004; 138: 286-87.
  12. Gillies M. C., Simpson J. M., Billson F. A. et al. Safety of an intravitreal injection of triamcinolone: results from a randomized clinical trial. Arch. Ophthalmol., 2004; 122: 336-40.
  13. Opatowsky I., Feldman R. M., Gross R., Feldman S. T. Intraocular pressure elevation associated with inhalation and nasal corticosteroids. Ophthalmology, 1995; 102: 177-79.
  14. Armaly M. F. Effect of corticosteroids on intraocular pressure and fluid dynamics: II. The effect of dexamethasone on the glaucomatous eye. Arch. Ophthalmol., 1963; 70: 492-99.
  15. Ohji M., Kinoshita S., Ohmi E., Kuwayama Y. Marked intraocular pressure response to instillation of corticosteroids in children. Am. J. Ophthalmol., 1991; 112: 450-54.
  16. Biedner B. Z., David R., Grudsky A., Sachs U. Intraocular pressure response to corticosteroids in children. Br. J. Ophthalmol., 1980; 64: 430-31.
  17. Lam D. S. C., Fan D. S. P., Ng J. S. K. et al. Ocular hypertensive and anti-inflammatory responses to different dosages of topical dexamethasone in children: a randomized trial. Clin. Exp. Ophthalmol., 2005; 33: 252-58.
  18. Gatson H., Absolon M. J., Thurtle O. A., Sattar M. A. Steroid responsiveness in connective tissue diseases. Br. J. Ophthalmol., 1983; 67: 487-90.
  19. Becker B. Diabetes mellitus and primary open-angle glaucoma. Am. J. Ophthalmol., 1971; 71: 1-16.
  20. Podos S. M., Becker B., Morton W. R. High myopia and primary open-angle glaucoma. Am. J. Ophthalmol., 1966; 62:1038-43.
  21. Cantrill H. L., Palmberg P., Zink H. A. et al. Comparison of in vitro potency of corticosteroids with ability to raise intraocular pressure. Am. J. Ophthalmol., 1975; 79: 1012-17.
  22. Bernstein H. N., Mills D. W., Becker B. Steroid-induced elevation of intraocular pressure. Arch. Ophthalmol., 1977; 9: 1075-80.
  23. Weinreb R. N., Polansky J. R., Kramer S. G., Baxter J. D. Acute effects of dexamethasone on intraocular pressure in glaucoma. Invest. Ophthalmol. Vis. Sci., 1985; 26: 170-75.
  24. Sihota R., Konkal V. L., Dada T., Agarwal H. C., Singh R.: Prospective, long-term evaluation of steroid-induced glaucoma. Eye (Lond), 2008; 22: 26-30.
  25. Jonas J. B., Degenrigh R. F., Kreissig I. et al. Intraocular pressure elevation after intravitreal triamcinolone acetonide injection. Ophthalmology, 2005; 112: 593-98.
  26. Smithen L. M., Ober M. D., Maranan L., Spaide R. F. Intravitrealtriamcinolone acetonide and intraocular pressure. Am. J. Ophthalmol., 2004; 138: 740-43.
  27. Clark A. F., Brotchie D., Read A. T. et al. Dexamethasone Alters F-actin architecture and promotes cross-linked actin network formation in human trabecular meshwork tissue. Cell Motil Cytoskeleton 2005; 60: 83-95.
  28. Yue BYJT. The extracellular matrix and its modulation in the trabecular meshwork. Surv. Ophthalmol., 1996; 40: 379-90.
  29. Johnson D. H., Bradley J. M., Acott T. S. The effect of dexamethasone on glycosaminoglycans of human trabecular meshwork in perfusion organ culture. Invest. Ophthalmol. Vis. Sci., 1990; 31: 2568-71.
  30. Kubota T. at al. Ultrastructure of the trabecular meshwork in secondary glaucoma eyes after triamcinolone acetonide. J. Glaucoma., 2006 Apr; 15 (2): 117-119.
  31. Johnson D. H., Bradley J. M., Acott T. S. The effect of dexamethasone on glycosaminoglycans of human trabecular meshwork in perfusion organ culture. Invest. Ophthalmol. Vis. Sci., 1990; 31: 2568-71.
  32. Wordinger R. J., Clark A. F. Effects of glucocorticoids on the trabecular meshwork: towards a better understanding of glaucoma. Prog. Retina Eye Res., 1999; 18: 629-667.
  33. Snyder R. W., Stamer W. D., Kramer T. R., Seftor R. E. B. Corticosteroid treatment and trabecular meshwork proteases in cell and organ culture supernatants. Exp. Eye Res., 1993; 57: 461-68.
  34. Weinreb R. N., Mitchell M. D., Polansky J. R. Prostaglandin production by human trabecular meshwork cells: in vitro inhibition by dexamethasone. Invest. Ophthalmol. Vis. Sci., 1983; 24: 1541-45.
  35. Shirato S., Bloom E., Polansky J. et al. Phagocytic properties of confluent human trabecular meshwork cells. Invest. Ophthalmol. Vis. Sci., 1988; 29: 125.
  36. Sihota R., Konkal V. L., Dada T., Agarwal H. C., Singh R. Prospective, long-term evaluation of steroid-induced glaucoma. Eye (Lond), 2008; 22: 26-30.
  37. Bollinger K. E., Smith S. D. Prevalence and management of elevated intraocular pressure after placement of an intravitreal sustained-release steroid implant. Curr. Opin. Ophthalmol., 2009; 20: 99-103.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2014 Vitovskaya O.P.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77-65574 от 04 мая 2016 г.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies